Back to Gene
EXT2 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

EXT2 gene

The EXT2 gene provides instructions for the exostosin-2 protein, which works with exostosin-1 to regulate heparan sulfate production and bone development.

Normal Function

The EXT2 gene provides instructions for producing a protein called exostosin-2. Like exostosin-1, this protein is found in the Golgi apparatus. It binds to exostosin-1 to form a complex that modifies heparan sulfate, a sugar-molecule complex essential for cell signaling, immune function, and the regulation of bone formation and cartilage development.

Health Conditions Related to Genetic Changes

Hereditary multiple osteochondromas

Pathogenic variants in the EXT2 gene cause hereditary multiple osteochondromas type 2. These "loss-of-function variants" prevent the production of functional exostosin-2. Without this protein, the complex with exostosin-1 cannot form, leading to improper heparan sulfate modification and the development of multiple benign bone tumors (osteochondromas).

Potocki-Shaffer syndrome

This condition is caused by a deletion of genetic material on chromosome 11. The loss of the EXT2 gene within this region results in multiple osteochondromas. Other features of the syndrome, such as enlarged parietal foramina (openings in the skull) and intellectual disabilities, are caused by the loss of additional genes in the same deleted region, such as ALX4 and PHF21A.

Other disorders

Pathogenic variants in the EXT2 gene have been linked to seizures-scoliosis-macrocephaly syndrome. In this condition, variants occur in both copies of the gene, leading to a reduction in functional exostosin-2. This disrupts heparan sulfate modification, resulting in symptoms including seizures, spinal curvature (scoliosis), an unusually large head (macrocephaly), intellectual disabilities, and low muscle tone (hypotonia).

Other Names for This Gene

  • exostosin 2
  • SOTV

Frequently Asked Questions

definitive diagnosis is made by DNA sequencing of the EXT2 gene from a blood or saliva sample. The test looks for pathogenic variants such as deletions, insertions, or point mutations that disrupt the gene’s function. The laboratory will report whether the mutation is inherited (germline) or new (de novo). A genetic counselor can help interpret the results and discuss family planning options.
Most osteochondromas are benign and require no intervention. However, if a tumor causes pain, nerve compression, or limits movement, surgical removal (excision) is usually recommended. The procedure involves cutting the tumor and removing the cartilage cap to reduce the risk of recurrence. Post‑operative physical therapy helps restore joint function. Regular imaging follow‑up is advised to monitor for new growths.
Children with EXT2-related osteochondromas often notice painless bumps or lumps near the ends of long bones, especially around the knees, hips, or elbows. They may also experience joint stiffness, limited range of motion, or occasional pain if a tumor compresses nearby nerves or blood vessels. Growth delays or limb length discrepancies can also be early clues. If you see any of these signs, a pediatric orthopedic evaluation and imaging (X‑ray or MRI) can confirm the diagnosis.
The risk of malignant transformation of an osteochondroma into chondrosarcoma is low but present, especially if the tumor grows rapidly or shows new pain. Annual physical exams, imaging of symptomatic lesions, and prompt evaluation of any new or changing masses are recommended. In some cases, a multidisciplinary team (orthopedics, genetics, oncology) may develop a personalized surveillance plan.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA